DI FILIPPO, PAOLA SOFIA
DI FILIPPO, PAOLA SOFIA
A multimodal approach to distinguish multiple sclerosis phenotypes at diagnosis using biomarker profiles
2025-01-01 Zanghi', A; Di Filippo, Paola Sofia; Greco, A; Rutigliano, C; Giancipoli, E; Iaculli, C; Avolio, C; D'Amico, E
Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab
2025-01-01 Zanghi', A; Di Filippo, Paola Sofia; Rutigliano, C; Avolio, C; D'Amico, E.
Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV IgG Tests in RRMS to Assess PML Risk
2025-01-01 Zanghi', A; Marinelli, F; Di Filippo, Paola Sofia; Avolio, C; D'Amico, E
Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMS
2025-01-01 Zanghi', A; DI FILIPPO, PAOLA SOFIA; Avolio, C; D'Amico, E.
Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study
2025-01-01 Zanghi', A; Di Filippo, Paola Sofia; Papale, M; Rutigliano, C; Moretti, Mc; Avolio, C; Corso, G; D'Amico, E.
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice
2026-01-01 Zanghi', A; Borriello, G; Foschi, M; Bianco, A; Signoriello, E; Cellerino, M; Di Filippo, Paola Sofia; Baldisseri, F; Romano, G; Cicia, A; Lus, G; Inglese, M; Mirabella, M; Avolio, C; D'Amico, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multimodal approach to distinguish multiple sclerosis phenotypes at diagnosis using biomarker profiles | 1-gen-2025 | Zanghi', A; Di Filippo, Paola Sofia; Greco, A; Rutigliano, C; Giancipoli, E; Iaculli, C; Avolio, C; D'Amico, E | |
| Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab | 1-gen-2025 | Zanghi', A; Di Filippo, Paola Sofia; Rutigliano, C; Avolio, C; D'Amico, E. | |
| Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV IgG Tests in RRMS to Assess PML Risk | 1-gen-2025 | Zanghi', A; Marinelli, F; Di Filippo, Paola Sofia; Avolio, C; D'Amico, E | |
| Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMS | 1-gen-2025 | Zanghi', A; DI FILIPPO, PAOLA SOFIA; Avolio, C; D'Amico, E. | |
| Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study | 1-gen-2025 | Zanghi', A; Di Filippo, Paola Sofia; Papale, M; Rutigliano, C; Moretti, Mc; Avolio, C; Corso, G; D'Amico, E. | |
| Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice | 1-gen-2026 | Zanghi', A; Borriello, G; Foschi, M; Bianco, A; Signoriello, E; Cellerino, M; Di Filippo, Paola Sofia; Baldisseri, F; Romano, G; Cicia, A; Lus, G; Inglese, M; Mirabella, M; Avolio, C; D'Amico, E |